| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 109,903 | 103,825 | 111,355 | 101,424 | | Cost of Revenue | 87,365 | 84,097 | 94,049 | 82,928 | | | Gross Profit | 22,538 | 19,728 | 17,306 | 18,496 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,647 | 12,135 | 12,809 | 14,606 | | Non Recurring |
-
|
-
|
-
| 13,064 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,891 | 7,593 | 4,497 | (9,174) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,886 | 7,593 | 4,497 | (9,174) | | Interest Expense | (1,353) | 714 | 639 | 294 | | Income Before Tax | 9,239 | 6,879 | 3,858 | (9,468) | | Income Tax Expense | 3,049 | 2,270 | 1,273 | (5,233) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,190 | 4,609 | 2,585 | (4,235) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,190 | 4,609 | 2,585 | (4,235) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,190 | $4,609 | $2,585 | ($4,235) |
|
0.26% Nasdaq 
Income Statement
